MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-09-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.432PMID 23001043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.

  2012cited by this paper
• Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL

  2012cited by this paper
• The molecular role of Fra‐1 and its prognostic significance in human esophageal squamous cell carcinoma

  2012cited by this paper
• Time for a Pause

  2011cited by this paper
• Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA

  2011cited by this paper
• miR-34 miRNAs provide a barrier for somatic cell reprogramming

  2011cited by this paper
• Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer

  2011cited by this paper
• A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition

  2011cited by this paper
• MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells*

  2011cited by this paper
• TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• miR‐340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c‐Met

  2011cited by this paper
• Wild-type p53 controls cell motility and invasion by dual regulation of MET expression

  2011cited by this paper
• miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions

  2011cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• The miR-34 family in cancer and apoptosis

  2010cited by this paper
• Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

  2010cited by this paper
• p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication

  2010cited by this paper
• MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines*

  2010cited by this paper
• p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC

  2010cited by this paper
• Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis.

  2010cited by this paper
• microRNA-34a is tumor suppressive in brain tumors and glioma stem cells

  2010cited by this paper
• Epigenetic inactivation of the miR-34a in hematological malignancies.

  2010cited by this paper
• Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

  2010cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

  2009cited by this paper
• miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.

  2009cited by this paper
• MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells

  2009cited by this paper
• Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.

  2009cited by this paper
• MicroRNAs — the micro steering wheel of tumour metastases

  2009cited by this paper
• The Role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression

  2009cited by this paper
• Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• A microRNA DNA methylation signature for human cancer metastasis

  2008cited by this paper
• A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

  2008cited by this paper
• The MYCN oncogene is a direct target of miR-34a

  2008cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• MicroRNAs impair MET-mediated invasive growth.

  2008cited by this paper
• Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

  2008cited by this paper
• Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest

  2008cited by this paper
• Ma et al. reply

  2008cited by this paper
• Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

  2007cited by this paper
• Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

  2007cited by this paper
• MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

  2007cited by this paper
• Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

  2007cited by this paper
• Activation of Rac by cadherin through the c-Src–Rap1–phosphatidylinositol 3-kinase–Vav2 pathway

  2006cited by this paper
• Tumor metastasis: mechanistic insights and clinical challenges

  2006cited by this paper
• Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells

  2005cited by this paper
• FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells

  2005cited by this paper
• The Role of the AP-1 Transcription Factors c-Fos, FosB, Fra-1 and Fra-2 in the Invasion Process of Mammary Carcinomas

  2004cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility

  2003cited by this paper
• High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer.

  2003cited by this paper
• Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells

  2003cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma.

  2003cited by this paper
• Alterations in gene expression and activity during squamous cell carcinoma development.

  2002cited by this paper
• Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

  2001cited by this paper
• FRA-1 expression in hyperplastic and neoplastic thyroid diseases.

  2000cited by this paper
• A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.

  2000cited by this paper
• Deletion mapping of chromosomal region 1p32‐pter in primary breast cancer

  1999cited by this paper
• Expression pattern of the AP‐1 family in breast cancer: Association of fosB expression with a well‐differentiated, receptor‐positive tumor phenotype

  1999cited by this paper
• Fra-1 Induces Morphological Transformation and Increases In Vitro Invasiveness and Motility of Epithelioid Adenocarcinoma Cells

  1998cited by this paper
• Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.

  1995cited by this paper
• Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.

  1995cited by this paper

• Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion

  2025cites this paper
• FRA1 (FOSL1) suppresses neoplastic transformation and modulates radiation responses via transcriptional control of mitogenic and stress-responsive networks

  2025cites this paper
• microRNA-34: A multifunctional miRNA family.

  2025cites this paper
• Clinical implications of serum miR-34a in breast cancer and its predictive value for the efficacy of neoadjuvant chemotherapy.

  2024cites this paper
• The Interplay Between Obesity and Aging in Breast Cancer and Regulatory Function of MicroRNAs in This Pathway

  2024cites this paper
• Bioinformatics Study and Experimental Evaluation of miR-182, and miR-34 Expression Profiles in Tuberculosis and Lung Cancer

  2024cites this paper
• Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy

  2024cites this paper
• Evaluating the Role of miR34a in Predicting Early Myocardial Damage in Breast Cancer Patients Undergoing Anthracycline-based Chemotherapy

  2024cites this paper
• Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications

  2024cites this paper
• FOSL1’s Oncogene Roles in Glioma/Glioma Stem Cells and Tumorigenesis: A Comprehensive Review

  2024cites this paper
• The role of MiRNA-34 family in different signaling pathways and its therapeutic options.

  2024cites this paper
• circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling.

  2023cites this paper
• Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors

  2023influential citation
• MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential

  2023cites this paper
• Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein

  2023cites this paper
• EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?

  2023cites this paper
• Intelligent identification system of gastric stromal tumors based on blood biopsy indicators

  2023cites this paper
• Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development

  2023cites this paper
• FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

  2023cites this paper
• Tumor suppressive functions of hsa-miR-34a on cell cycle, migration and protective autophagy in bladder cancer

  2023cites this paper
• MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway

  2023cites this paper
• Microfluidics for detection of exosomes and microRNAs in cancer: State of the art

  2022cites this paper
• The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases

  2022cites this paper
• Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins

  2022cites this paper
• miRNA‐34c‐5p targets Fra‐1 to inhibit pulmonary fibrosis induced by silica through p53 and PTEN/PI3K/Akt signaling pathway

  2022cites this paper
• microRNA-34 Family: From Mechanism to Potential Applications.

  2022cites this paper
• Study to Identify the Signalling Cascade behind Expression Level of PTEN and RB1 gene in Breast Cancer

  2022cites this paper
• The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting

  2022cites this paper
• Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas

  2022cites this paper
• Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis

  2022cites this paper
• A miR-34a-guided, tRNAiMet-derived, piR_019752-like fragment (tRiMetF31) suppresses migration and angiogenesis of breast cancer cells via targeting PFKFB3

  2022cites this paper
• Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer

  2022cites this paper
• Multiomics Topic Modeling for Breast Cancer Classification

  2021cites this paper
• miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy

  2021cites this paper
• The comprehensive landscape of miR-34a in cancer research

  2021cites this paper
• The Effect of Metformin on the Proliferation, Apoptosis and CD133 mRNA Expression of Colon Cancer Stem Cells by Upregulation of miR 342-3p

  2021cites this paper
• The Effect of Micro RNA-34a and carboplatin combination on the inducing apoptosis of Breast Cancer Cell line

  2021cites this paper
• MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes.

  2021cites this paper
• Obesity, leptin, and deregulation of microRNA in lipid metabolisms: their contribution to breast cancer prognosis

  2021cites this paper
• Could miR34a be as a Potential Biomarker for Doxorubicin Induced Cardiotoxicity?

  2021cites this paper
• Micro RNA-34a sensitizes MCF-7 Breast Cancer Cells to carboplatin through the apoptosis induction

  2021cites this paper
• FosL1 Regulates Regional Metastasis of Head and Neck Squamous Cell Carcinoma by Promoting Cell Migration, Invasion, and Proliferation

  2021cites this paper
• Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.

  2021cites this paper
• PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma.

  2020cites this paper
• miR-195 down-regulation is a distinctive biomarker of HER2 positive state in breast cancer

  2020cites this paper
• Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma

  2020cites this paper
• Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy.

  2020cites this paper
• The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door

  2020cites this paper
• A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies

  2020cites this paper
• MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing

  2020cites this paper
• Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis

  2020cites this paper
• Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis

  2020cites this paper
• Adipocyte-Derived Leptin Promotes PAI-1-Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner

  2020cites this paper
• microRNA‐related single‐nucleotide polymorphisms and breast cancer

  2020cites this paper
• MiR-194 promotes hepatocellular carcinoma through negative regulation of CADM1.

  2020cites this paper
• MicroRNAs in breast cancer: New maestros defining the melody.

  2020cites this paper
• Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer

  2020cites this paper
• S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a

  2020cites this paper
• MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.

  2019cites this paper
• Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy

  2019cites this paper
• Effect of miR-34a on resistance to sunitinib in breast cancer by regulating the Wnt/β-catenin signaling pathway.

  2019cites this paper
• Small non-coding RNAs as a tool for personalized therapy in familial cancers

  2019cites this paper
• Emerging Epigenetic Targets and Their Implications in Cancer Therapy

  2019cites this paper
• MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

  2019cites this paper
• Therapeutic Potential of the microRNA-ATM Axis in the Management of Tumor Radioresistance.

  2019cites this paper
• MiR-506-3 p inhibits proliferation and invasion by targeting EZH 2 in glioblastomas

  2019cites this paper
• Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma

  2019cites this paper
• Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.

  2019cites this paper
• Effects of MicroRNAs from Marine Invertebrate Stress Responses to Virus Infection on Tumorigenesis

  2019cites this paper
• Development of double strand RNA mPEI nanoparticles and application in treating invasive breast cancer

  2019cites this paper
• Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients.

  2019cites this paper
• The Role of miRNAs from the 14q32 Region in Acquired Resistance to Lapatinib

  2019cites this paper
• FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma

  2019cites this paper
• Expression and function of FRA1 protein in tumors

  2019cites this paper
• EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.

  2019cites this paper
• Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma

  2019cites this paper
• Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.

  2019cites this paper
• Delivery of biologically active miR-34a in normal and cancer mammary epithelial cells by synthetic nanoparticles.

  2019cites this paper
• microRNAs‐107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1

  2018cites this paper
• Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway.

  2018cites this paper
• Role of dietary phytochemicals in modulation of miRNA expression: Natural swords combating breast cancer

  2018cites this paper
• S-Adenosylmethionine regulates apoptosis and autophagy in MCF-7 breast cancer cells through the modulation of specific microRNAs

  2018cites this paper
• microRNA‐130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO‐1

  2018cites this paper
• Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness

  2018cites this paper
• MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis

  2018cites this paper
• An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancer

  2018cites this paper
• Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion

  2018cites this paper
• Expression and polymorphism of micro‐RNA according to body mass index and breast cancer presentation in Tunisian patients

  2018cites this paper
• MicroRNA-34 family in breast cancer: from research to therapeutic potential

  2018influential citation
• Regulation of miR-34b/c-targeted gene expression program by SUMOylation

  2018cites this paper
• miR-34a directly targets tRNAiMet precursors and affects cellular proliferation, cell cycle, and apoptosis

  2018cites this paper
• The effects of aberrant expression of LncRNA DGCR5/miR‐873‐5p/TUSC3 in lung cancer cell progression

  2018cites this paper
• Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA

  2018cites this paper
• Sulforaphane inhibits human bladder cancer cell invasion by reversing epithelial-to-mesenchymal transition via directly targeting microRNA-200c/ZEB1 axis

  2018cites this paper
• miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.

  2017cites this paper
• Kallistatin suppresses cancer development by multi-factorial actions.

  2017cites this paper
• The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation

  2017cites this paper
• Unravelling a p73-regulated network: The role of a novel p73-dependent target, MIR3158, in cancer cell migration and invasiveness.

  2017cites this paper
• Discovery of microRNAs and Transcription Factors Co-Regulatory Modules by Integrating Multiple Types of Genomic Data

  2017cites this paper
• MiR‐155 inhibits proliferation and invasion by directly targeting PDCD4 in non‐small cell lung cancer

  2017cites this paper